Bank of Nova Scotia Trust’s Avanos Medical AVNS Stock Holding History

Bank of Nova Scotia Trust’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-44	Closed	-$2K	–	151
2017 Q3	$2K	Buy	+44	New	+$1.88K	﹤0.01%	420

Other funds holding AVNS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of Nova Scotia Trust's AVNS Position: Q4 2017 in Review

Bank of Nova Scotia Trust sold out of Avanos Medical (AVNS) in Q4 2017, closing a stake of 44 shares — an estimated $2K sold.

Bank of Nova Scotia Trust first reported a position in AVNS in Q3 2017 and held it in 1 quarter. The position peaked at $2K in Q3 2017. 350 funds tracked by Wall St. Rank hold AVNS as of Q4 2017.

Bank of Nova Scotia Trust reported no remaining Avanos Medical position as of Q4 2017 after selling out during the quarter.
Bank of Nova Scotia Trust sold 44 Avanos Medical shares in Q4 2017, an estimated $2K.
Bank of Nova Scotia Trust first reported a position in Avanos Medical in Q3 2017 and held it in 1 quarter.
Bank of Nova Scotia Trust's Avanos Medical position peaked at $2K in Q3 2017.
350 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2017.

Based on Bank of Nova Scotia Trust's 13F filing for Q4 2017, filed 13 Feb 2018.